The terminal plasma half-life is the time required to halve the plasma concentration after reaching pseudo-equilibrium, not the time required to eliminate half the administered dose. When the absorption process is not a limiting factor, the half-life is a hybrid parameter controlled by the plasma clearance and the extent of the distribution. On the other hand, when the absorption process is a limiting factor, the terminal half-life reflects the rate and extent of absorption and not the elimination process (pharmacokinetics of the scales). The terminal half-life is particularly relevant for multiple dosing regimens, as it controls the degree of drug accumulation, concentration fluctuations, and the time required to reach equilibrium.
Editorial: Malaria Control & Elimination
Editorial: Malaria Control & Elimination
Research Article: Malaria Control & Elimination
Research Article: Malaria Control & Elimination
Review Article: Malaria Control & Elimination
Review Article: Malaria Control & Elimination
Research Article: Malaria Control & Elimination
Research Article: Malaria Control & Elimination
Research Article: Malaria Control & Elimination
Research Article: Malaria Control & Elimination
Posters & Accepted Abstracts: Nuclear Medicine & Radiation Therapy
Posters & Accepted Abstracts: Nuclear Medicine & Radiation Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters-Accepted Abstracts: Journal of Bioengineering & Biomedical Science
Posters-Accepted Abstracts: Journal of Bioengineering & Biomedical Science
Malaria Control & Elimination received 1187 citations as per Google Scholar report